Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint ...

Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...

Tukysa (tucatinib) combined with Herceptin (trastuzumab) and Perjeta (pertuzumab) extended progression-free survival as a frontline maintenance approach compared with placebo plus Herceptin and ...

Everyone talks about turmeric and salmon when discussing anti-inflammation. You've heard it all before. Maybe you're tired of ...

E. Strunk, A. Lobert, T. Khorovich, K. M. Guzman Lucio, R. Richarz, M. Hohmann, P. M. D'Agostino, T. A. Gulder. Biosynthesis of the biphenomycin family of potent antibiotics. Angew. Chem. Int. Ed.

A new study has developed a powerful computational method that can detect how genes interact with each other to influence complex traits in humans at a scale previously impossible.

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...